1. 1800 Final results for overall survival (OS), the primary endpoint of the CECOG TURANDOT prospective randomised trial evaluating bevacizumab-paclitaxel (BEV-PAC) vs BEV-capecitabine (CAP) for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC). Issue 3 (September 2015) Authors: Zielinski, C.C.; Lang, I.; Inbar, M.; Kahan, Z.; Greil, R.; Beslija, S.; Stemmer, S.M.; Zvirbule, Z.; Steger, G.G.; Melichar, B.; Pienkowski, T.; Sirbu, D.; Petruzelka, L.; Eniu, A.; Nisenbaum, B.; Dank, M.; Anghel, R.; Messinger, D.; Brodowicz, T. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P169 Clinical outcomes in patients (pts) with estrogen receptor (ER)+ stage I breast cancer (BC) and Recurrence Score (RS) 26–30: Real-world data. (April 2023) Authors: Rotem, O.; Peretz, I.; Leviov, M.; Kuchuk, I.; Itay, A.; Tokar, M.; Paluch-Shimon, S.; Maimon, O.; Yerushalmi, R.; Drumea, K.; Evron, E.; Sonnenblick, A.; Gal-Yam, E.; Goldvaser, H.; Yosef, S.; Merose, R.; Bareket-Samish, A.; Soussan-Gutman, L.; Stemmer, S.M. Journal: Breast Issue: Volume 68(2023)Supplement Page Start: S81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rational design of combination therapies and blockage of acquired targeted drug resistance. (July 2016) Authors: Reuveni, H.; Kupershmidt, L.; Carmi, S.; Moskovitz, N.; Rozen, M.; Shlapoberski, M.; Golomb, E.; Lotem, M.; Stemmer, S.M.; Haviv, I. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ribociclib + letrozole for first-line treatment of HR+, HER2− ABC: efficacy, safety, and pharmacokinetics. (December 2016) Authors: André, F.; Stemmer, S.M.; Hortobagyi, G.N.; Burris, H.A.; Paluch-Shimon, S.; Campone, M.; Villanueva, C.; Chan, A.; Wist, E.; Marschner, N.; Bachelot, T.; Blau, S.; Janni, W.; Verma, S.; Conte, P.; Dhuria, S.; Yang, S.; Stegert, M.; Germa, C.; Arteaga, C.L. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ten-year clinical outcomes in >1000 node-negative (N0) Estrogen Receptor (ER)+ breast cancer (BC) patients (Pts) where treatment decisions incorporated the Recurrence Score Results: a registry analysis using TAILORx categorization. (March 2019) Authors: Stemmer, S.M.; Leviov, M.; Tokar, M.; Ben-Baruch, N.; Uziely, B.; Fried, G.; Rosengarten, O.; Itay, A.; Nisenbaum, B.; Shak, S. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗